Lv1
50 积分 2023-04-26 加入
克唑替尼在中国ALK基因重排的非小细胞肺癌人群中临床疗效的异质性研究
6天前
已完结
Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma
6个月前
已完结
Comparing the Efficacy and Safety of First-Line Treatments for Chronic Lymphocytic Leukemia: A Network Meta-Analysis
6个月前
已关闭
Multiple primary lung cancer: Updates and perspectives
6个月前
已完结
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
11个月前
已关闭
[Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)]
1年前
已完结
Iruplinalkib (WX-0593) versus crizotinib in ALK TKI-naïve locally advanced or metastatic ALK-positive non-small cell lung cancer: interim analysis of a randomized, open-label, phase III study (INSPIRE)
1年前
已完结
Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer
1年前
已完结
中国恶性胸膜间皮瘤临床诊疗指南
1年前
已完结
[Chinese expert consensus on immunotherapy for advanced non-small lung cancer with oncogenic driver mutations (2023 edition)]
1年前
已完结
皖公网安备34019202002308
